Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration

Gene Therapy

Volumn 5, Issue 4, 1998, Pages 451-458

  Van der Eb, M M ^a   Cramer, S J ^a   Vergouwe, Y ^a   Schagen, F H E ^a   Van Krieken, J H J M ^a   Van der Eb, A J ^a   Borel Rinkes, I H M ^b   Van de Velde, C J H ^a   Hoeben, R C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cancer gene therapy; Rat; Suicide gene; Toxicity

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; THYMIDINE KINASE; VIRUS ENZYME; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; LIVER DYSFUNCTION; LIVER METASTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUICIDE GENE;

ADENOVIRIDAE; ANIMALIA; HERPES; SIMPLEXVIRUS;

EID: 0031919447     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300637     Document Type: Article

References (53)

1. Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
2. Smyth WR et al. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasma: an effective in vitro drug sensitization system. Cancer Res 1994; 54: 2055-2059.
3. Qian C, Bilbao R, Bruňa O, Prieto J. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology 1995; 22: 118-123.
4. Ram Z et al. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg 1994; 81. 256-260.
5. Caruso M et al. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 1993; 90: 7024-7028.
6. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5281.
7. Grossman M et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 1994; 6: 335-341.
8. Nabel EG, Plautz GE, Nabel GJ. Recombinant growth factor gene expression in vascular cells in vivo. Ann NY Acad Sci 1994; 714: 247-252.
9. Naviaux RK, Verma IM. Retroviral vectors for persistent expression in vivo. Curr Opin Biotechnol 1992; 3. 540-547.
10. Lieber A et al. Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo. Proc Natl Acad Sci USA 1995; 92: 6210-6214.
11. Rosenfeld MA et al. Adenovirus-mediated transfer of a recombinant α 1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431-434.
12. Quantin B, Perricaudet LD, Tajbakhsh S, Mandel J-L. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 1992; 89: 2581-2584.
13. Le Gal La Salle G et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993; 259: 988-990.
14. Smith TAG et al. Adenovirus-mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 1993; 5: 397-402.
15. Huard J et al. The route of administration is a major determinant of transduction efficiency of rat tissues by adenoviral recombinants. Gene Therapy 1995; 2: 107-115.
16. Li Q et al. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 1993; 4: 403-409.
17. Jaffe HA et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver Nat Genet 1992; 1: 372-379.
18. Cordier L et al. Complete recovery of mice from pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Therapy 1995; 2: 16-21.
19. Eck SL et al. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK a phase 1 trial. Hum Gene Ther 1996; 7: 1465-1482.
20. Chen SH et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA 1995; 92: 2577-2581.
21. Ackerman NB, Lien WM, Kondi ES, Silverman NA. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to 'small' and 'large' tumors. Surgery 1969; 66: 1067-1072.
22. Ploemacher RE, van Soest PL, Vos O Kinetics of erythropoiesis in the liver induced in adult mice by phenylhydraxine. Scand J Haematol 1977; 19: 424-434.
23. Deimann W, Strobel ES. Activated macrophages induce hemopoietic islands in the adult rat liver. Blood Cells 1991; 17: 97-101.
24. Piacentini G et al. Hepatic hematopoiesis in phenylhydrazine-induced hemolytic anemia. Boll Soc Ital Biol Sper 1990; 66: 725-728.
25. De Roos WK et al. Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver. Gene Therapy 1997; 4: 55-62.
26. Mitani K, Graham FL, Caskey CT. Transduction of human bone marrow by adenoviral vector. Hum Gene Ther 1994; 5: 941-948.
27. Watanabe T et al. Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors. Blood 1996; 87: 5032-5039.
28. Brand K et al. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer Gene Ther 1997; 4: 9-16.
29. Wallace H et al. Ganciclovir-induced ablation of non-proliferating thyrocytes expressing herpes thymidine kinase occurs by p53-independent apoptosis. Oncogene 1996; 13: 55-61.
30. Chen CH, Cheng YC. The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2′,3′-dideoxycytidine. J Biol Chem 1992; 267: 2856-2859.
31. Lewis W, Gonzales B, Chomyn A, Papoian T. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest 1992; 89: 1354-1360.
32. Lewis W et al. Fialuridine and its metabolites inhibits DNA polymerase γ at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. Proc Natl Acad Sci USA 1996; 93: 3592-3597.
33. Colacino JM, Malcolm SK, Jaskunas SR. Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture. Antimicrob Agents Chemother 1994; 38: 1997-2002.
34. Cui L, Yoon S, Schinazi RF, Sommadossi JP. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-β-D-arabinofuranosyl)-5-iodouracil in human liver cells. J Clin Invest 1995; 95: 555-563.
35. Lewis LD, Hamzeh FM, Lietman PS Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2′3′-dideoxycytidine. Antimicrob Agents Chemother 1992; 36: 2061-2065.
36. Freiman IP, Helfert KE, Hamrell MR, Stein DS. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 1993; 7: 379-385.
37. Bakker HD et al. Depletion of mitochondrial deoxyribonucleic acid in a family with fatal neonatal liver disease. J Pediatr 1996; 128: 683-687.
38. Dalakas MC et al. Mitochondrial myopathy caused by long-term zidovudine therapy. New Engl J Med 1990; 322: 1098-1105.
39. Gonipath R, Hutcheon M, Cheema-Dhadli S, Halperin M. Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies. J Am Soc Nephrol 1992; 3: 1212-1219.
40. Mckenzie R et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. New Engl J Med 1995; 333: 1099-1105.
41. Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 1996; 70: 6839-6846.
42. Stevenson SC, Rollence M, Marshall-Neff J, McClelland A Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J Virol 1997; 71: 4782-4790.
43. Wickham TJ et al. Targeting adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol 1996; 70: 6831-6838.
44. Lan KH et al. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma. Cancer Res 1997; 57: 4279-4284.
45. Ring CJ, Harris JD, Hurst HC, Lemoine NR. Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promotor. Gene Therapy 1996; 3: 1094-1103.
46. Sterman DH et al. Recombinant adenoviral-mediated intrapleural gene therapy for malignant mesothelioma: preliminary findings of a phase I clinical trial. Gene Therapy Weekly 1996; August 19: 20-21.
47. Thomas C et al. Liver metastases model of colon cancer in the rat: immunohistochemical characterization. Invas Metas 1993; 13: 102-112.
48. Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993; 90: 2812-2816.
49. Esandi MC et al. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Gene Therapy 1997; 4: 280-287.
50. Fallaux FJ et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 1996, 7. 215-222.
51. Damoiseaux JG et al. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994; 83: 140-147.
52. Matsumoto Y, Tsuchida M, Hanawa H, Abo T. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor αβ antibody. Immunology 1994; 81: 1-7. Reference added in proof
53. Bramson JL, Hitt M, Gauldie J, Graham FL. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Therapy 1997; 4: 1069-1076.